14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PMCB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Pharmacyt Biotch stock price ended at $2.13 on Tuesday, after losing 4.05%.
(Updated on Apr 23, 2024)

Sell candidate since Apr 12, 2024 Loss -4.48% PDF

The Pharmacyt Biotch stock price fell by -4.05% on the last day (Tuesday, 23rd Apr 2024) from $2.22 to $2.13. During the last trading day the stock fluctuated 2.35% from a day low at $2.13 to a day high of $2.18. The price has fallen in 6 of the last 10 days and is down by -7.39% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 thousand shares and in total, 2 thousand shares were bought and sold for approximately $3.20 thousand.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.13 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.62% during the next 3 months and, with a 90% probability hold a price between $2.27 and $2.72 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PMCB Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 0.95%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pharmacyt Biotch stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.15 and $2.23. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pharmacyt Biotch stock

Pharmacyt Biotch finds support from accumulated volume at $2.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0500 between high and low, or 2.35%. For the last week the stock has had daily average volatility of 6.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PMCB) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Pharmacyt Biotch to open at $2.15, and during the day (based on 14 day Average True Range), to move between $2.00 and $2.26, which gives a possible trading interval of +/-$0.131 (+/-6.14%) up or down from last closing price. If Pharmacyt Biotch takes out the full calculated possible swing range there will be an estimated 12.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.14 (0.47%) than the support at $2.06 (3.29%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pharmacyt Biotch stock A Buy?

The Pharmacyt Biotch stock holds several negative signals and despite the positive trend, we believe Pharmacyt Biotch will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.685 Sell Candidate Unchanged

Predicted Opening Price for Pharmacyt Biotch of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$2.15 ( 0.782%) $2.13

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PMCB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.20 3.13 %
R2 2.18 2.23 %
R1 2.17 1.68 %
Current price: 2.13
Support S1 2.13 -0.114 %
S2 2.12 -0.668 %
S3 2.10 -1.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.44 14.55 %
R2 2.38 11.74 %
R1 2.14 0.469 %
Current price 2.13
Support S1 2.06 -3.29%
S2 2.05 -3.76%
S3 2.01 -5.63%

FAQ

What is the symbol for Pharmacyt Biotch Stock and on which exchange is it traded?
The symbol for Pharmacyt Biotch is PMCB and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Pharmacyt Biotch Stock?
The Pharmacyt Biotch stock holds several negative signals and despite the positive trend, we believe Pharmacyt Biotch will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Pharmacyt Biotch Stock?
Pharmacyt Biotch Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharmacyt Biotch Stock.

What's the current price of Pharmacyt Biotch Stock?
As of the end of day on the Apr 23, 2024, the price of an Pharmacyt Biotch (PMCB) share was $2.13.

What is the 52-week high and low for Pharmacyt Biotch Stock?
The 52-week high for Pharmacyt Biotch Stock is $3.23 and the 52-week low is $1.92.

What is the market capitalization of Pharmacyt Biotch Stock?
As of the Apr 23, 2024, the market capitalization of Pharmacyt Biotch is 18.03M.

When is the next earnings date for Pharmacyt Biotch?
The upcoming earnings date for Pharmacyt Biotch is Jul 29, 2024.
Click to get the best stock tips daily for free!

About Pharmacyt Biotch

Pharmacyt Biotch PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin... PMCB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT